Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biogen pays Elan $3.25 billion to take over MS drug
Biogen pays Elan $3.25 billion to take over MS drug
Biogen pays Elan $3.25 billion to take over MS drug
Submitted by
admin
on February 6, 2013 - 8:25am
Source:
Reuters
News Tags:
Biogen Idec
Elan
Tysabri
M&A
MS
multiple sclerosis
Headline:
Biogen pays Elan $3.25 billion to take over MS drug
Do Not Allow Advertisers to Use My Personal information
